Regulatory & Antitrust: VLSI/Intel, Nvidia/Groq, EU DMA, FDA Leadership, NextEra/Dominion

Synthesized from web research on 2026-05-30. Sources: IPWatchdog, Justia CAFC, Warren Senate, BioPharma Dive, SEC EDGAR, Utility Dive, EU Commission, Tom's Hardware, TechTimes. Treat named figures as reported; verify primary sources for citations.

VLSI Technology LLC v. Intel — Trial Status

April 2026 Federal Circuit Ruling (Key Reversal)

The CAFC reversed two of Intel's summary judgment wins on April 14, 2026 (No. 24-1772):

1. Extraterritoriality reversal: Parties had stipulated 70% of Intel's activities had US nexus; appellate court found that stipulation does NOT constitute a noninfringement admission — reversed.
2. Doctrine of equivalents reversal: For claims 10, 11, 13, and 17 of U.S. Patent No. 8,566,836 ("Multi-core System on Chip"), the Federal Circuit found the lower court wrongly imported prosecution disclaimer limitations — reversed.

Sources: IPWatchdog, Justia CAFC No. 24-1772

Damages Situation

• Federal Circuit affirmed striking of VLSI damages expert Dr. Sullivan's NPV and VPU theories; VLSI retains Mr. Chandler's opinions on remand
• Prior verdicts in related cases: VLSI has won >$3 billion in patent infringement verdicts against Intel in Texas federal court, including a $2.18 billion jury verdict + $162 million in prejudgment interest
• These set the ceiling expectation for comparable damages in the remand proceeding
• Source: Parola Analytics

June 2026 Trial

Available sources confirm an upcoming remand trial but do not surface a confirmed June 14–18 date in public dockets. The case is in the Northern District of California on remand. Damages on the '836 patent remand will depend heavily on Chandler's royalty methodology — not publicly estimated yet.

Intel (INTC) exposure: Headline risk if the June trial proceeds and yields a multi-hundred-million verdict. Not existential, but adds to ongoing legal overhang alongside PTAB proceedings.

Nvidia/Groq Acquisition — Regulatory Status

Deal Structure

The December [2025] $20 billion deal is structured as a licensing-plus-acqui-hire — Groq's key assets and CEO/senior engineers transferred to Nvidia while Groq nominally remains a separate legal entity. This structure was deliberately constructed to fall outside Hart-Scott-Rodino premerger notification thresholds, which apply to acquisitions but not licensing agreements.

Source: Warren Senate press release

Congressional Pressure

Senators Warren and Blumenthal sent a March 2026 letter to Jensen Huang demanding explanation by April 3, 2026. They argued Nvidia — with 80–90% AI training GPU market share — is "acquiring Groq in all but name" to eliminate a nascent inference-chip competitor. Urged FTC/DOJ to investigate.

Source: Warren Senate letter PDF

Current Status (May 2026)

No formal FTC or DOJ enforcement action announced against the Groq deal specifically. However, a broader DOJ antitrust probe into Nvidia's AI chip market practices — including alleged bundling tactics and the RunAI acquisition — is ongoing with third-party subpoenas.

After the Groq deal closed, OpenAI reportedly abandoned Groq chip deployment discussions and purchased additional Nvidia GPUs — concrete evidence of reduced competitive pressure that DOJ economists would find relevant.

Sources: Tom's Hardware: DOJ Nvidia antitrust investigation, Kavout

NVDA positioning: Regulatory overhang but no near-term enforcement event. The licensing structure is a meaningful shield; precedent for treating it as HSR-notifiable would require a DOJ/FTC civil action or new legislation.

China-Russia Antitrust Coordination (May 25, 2026)

China's SAMR and Russia's FAS signed a 2026–2027 bilateral antitrust cooperation memorandum on May 25, 2026. Formalizes coordinated enforcement capacity against:

• Nvidia: Active SAMR probe since December 2024 over Mellanox acquisition condition violations; preliminary breach finding September 2025 — NOT closed despite Trump-Xi May 2026 summit
• Qualcomm (QCOM): SAMR investigation into Autotalks acquisition opened October 2025 — NOT closed

Source: TechTimes May 27, 2026

EU DMA/DSA Enforcement Against US-Listed Companies

Google — Record DMA Fine

EU issued a record DMA fine against Google in 2026 for search practices. The €4.3 billion figure triggered President Trump's threat of 25% retaliatory tariffs on EU tech companies. Google proposed news search display changes in May 2026 to preempt further enforcement action.

Source: European Business Magazine

Meta — DSA Preliminary Finding (April 29, 2026)

European Commission issued preliminary findings that Meta breached the Digital Services Act by failing to prevent children under 13 from accessing Instagram and Facebook (age-verification mechanisms easily bypassed). Potential fine: up to 6% of global annual turnover — on 2025 revenue, exceeds $12 billion. This is preliminary; Meta has right of defense before any final decision.

Sources: EC press corner, Business Standard

Prior DMA Fines (2025)

• Apple: €500 million (App Store DMA violation; in appeal)
• Meta: €200 million (consent-or-pay DMA violation; in appeal)

Cloud Investigation (Amazon, Microsoft)

EU cloud computing investigations against Amazon (AWS) and Microsoft (Azure) initiated November 2025. Described as "the next enforcement frontier" under DMA/DSA. No preliminary findings yet as of May 2026.

Source: Captain Compliance

FDA Leadership Vacuum and Biotech Implications

Makary Resignation (May 12, 2026)

FDA Commissioner Marty Makary resigned May 12, 2026. Kyle Diamantas appointed acting commissioner. Three top FDA positions — including drug review and regulation leadership — now held by "acting" officials, all with 210-day statutory time limits, making further turnover likely.

Source: BioPharma Dive

Prior departures

Peter Marks (biologics), Richard Pazdur (oncology), and others left earlier — significant institutional knowledge loss in the review pipeline.

Implications

Biotech-friendly initiatives Makary endorsed — rare disease acceleration, biosimilar streamlining, CMC modernization — may not continue under an unknown permanent replacement. The HHS secretary (RFK Jr.) and White House control who the next permanent commissioner is. The user fee agreement reauthorizations expiring September 30, 2027 (covering prescription drugs, biologics, devices, biosimilars, generics) are now complicated with acting leadership.

Drug developers with late-stage NDA/BLA submissions and PDUFA dates in 2026 Q2–Q3 face higher variance — particularly smaller biotechs.

NextEra/Dominion Merger (Announced May 15, 2026)

Transaction

NextEra Energy (NEE) agreed to acquire Dominion Energy (D) in an all-stock transaction, creating the world's largest regulated electric utility — 10 million customers across four states, ~110 GW combined. The combined entity would have a 130 GW large-load pipeline.

Source: Utility Dive

Required Approvals (ALL PENDING)

• FERC
• NRC (Dominion has nuclear assets)
• Virginia State Corporation Commission (most uncertain hurdle given Dominion's rate-case history)
• North Carolina Utilities Commission
• South Carolina Public Service Commission
• HSR Act antitrust clearance

Timeline: 12–18 months to close (mid-to-late 2027 at earliest). No approvals granted yet. Source: SEC EDGAR Dominion Form 425, Virginia Mercury

Positioning: NEE stock faces near-term equity dilution as acquirer; D shareholders receive all-stock consideration at a premium that only materializes if deal closes. Virginia regulatory commission is the key gating hurdle.

Summary Table

Company	Development	Direction
Intel (INTC)	VLSI remand trial June 2026; Federal Circuit reinstated infringement claims	Negative (damages exposure)
Nvidia (NVDA)	No formal Groq enforcement; DOJ broad probe ongoing; SAMR probe unresolved	Negative overhang
Qualcomm (QCOM)	SAMR Autotalks investigation unresolved; China-Russia antitrust MOU	Negative overhang
Alphabet/Google (GOOGL)	EU DMA record fine; forced news search changes; cloud probe building	Negative (ongoing EU friction)
Meta (META)	DSA preliminary finding April 29 — potential $12B+ fine; DMA appeals	Negative (material EU fine risk)
Apple (AAPL)	€500M DMA fine in appeals; cloud probe emerging	Negative (ongoing)
Amazon (AMZN)	EU cloud/DMA probe initiated Nov 2025	Negative (developing)
Microsoft (MSFT)	EU cloud/DMA probe initiated Nov 2025	Negative (developing)
NextEra Energy (NEE)	Acquiring Dominion; stock-based deal with 12–18mo regulatory risk	Mixed (strategic if cleared; dilution risk)
Dominion Energy (D)	Being acquired by NEE; 12–18mo regulatory uncertainty	Mixed (premium if deal closes)
Biotech broadly	FDA acting leadership vacuum; 210-day clocks on all top roles	Negative (regulatory variance elevated)

Provenance

• IPWatchdog: VLSI Scores Reversal Against Intel at CAFC
• Justia CAFC No. 24-1772
• Parola Analytics: Intel VLSI Patent Dispute
• Finnegan: Hedonic Regression Damages Framework
• Warren Senate: Nvidia Groq Press Release
• Warren Senate: Nvidia Groq Letter PDF
• Tom's Hardware: DOJ Nvidia Antitrust Investigation
• TechTimes: China-Russia Antitrust Alliance, May 27, 2026
• European Business Magazine: EU DMA Google Fine
• EC: Meta DSA Preliminary Finding
• BioPharma Dive: Makary FDA Resign
• Utility Dive: NextEra-Dominion 130 GW Large-Load Pipeline
• SEC EDGAR Dominion Form 425
• Virginia Mercury: NextEra-Dominion Virginia Customers